LeydenJar wins the Peter Wennick Tech Award 2026
LeydenJar has been awarded the prestigious Peter Wennink Tech Award 2026 in recognition of its breakthrough work in next-generation battery technology.
1 to 6 of 146 results
LUMC presents an innovative treatment for pulmonary embolism
LUMC is pioneering an innovative approach with a new catheter-based treatment for pulmonary embolism, enabling patients to recover more quickly and reducing the risk of death.
New LUMC research highlights the potential of cancer medicines
For patients with advanced cancer, standard treatments may no longer be effective. Research by the LUMC suggests that off-label medicines may offer a potential alternative treatment.
The tiniest personal trainer lives in your gut
Growing older naturally coincides with a gradual loss of muscle mass and strength. Researchers at the LUMC and the Universities of Granada and AlmerÃa discovered a gut bacterium that may aid in slowing, or even preventing, this process.
Breakthrough in research into the treatment of metastatic ocular melanoma
Researchers at the LUMC have found that a combination of liver perfusion and immunotherapy can significantly improve the life expectancy of patients with metastatic ocular melanoma.
The LUMC has received large-scale funding to support new stem cell research.
LUMC has received tens of millions for new research based on stem cells. The partnership between LUMC and reNEW consortium, aims to develop new treatments for partients with chronic diseases.